Cargando…

Prognostic value of lymph node involvement in oral squamous cell carcinoma

OBJECTIVES: Different parameters have been identified in patients with oral squamous cell carcinomas (OSCC) that have a serious impact on survival, including residual tumour and extracapsular spread. Moreover, other factors, including the lymph node ratio (LNR) and lymph node yield (LNY), have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Voss, Jan Oliver, Freund, Lea, Neumann, Felix, Mrosk, Friedrich, Rubarth, Kerstin, Kreutzer, Kilian, Doll, Christian, Heiland, Max, Koerdt, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643253/
https://www.ncbi.nlm.nih.gov/pubmed/35895143
http://dx.doi.org/10.1007/s00784-022-04630-7
_version_ 1784826481238605824
author Voss, Jan Oliver
Freund, Lea
Neumann, Felix
Mrosk, Friedrich
Rubarth, Kerstin
Kreutzer, Kilian
Doll, Christian
Heiland, Max
Koerdt, Steffen
author_facet Voss, Jan Oliver
Freund, Lea
Neumann, Felix
Mrosk, Friedrich
Rubarth, Kerstin
Kreutzer, Kilian
Doll, Christian
Heiland, Max
Koerdt, Steffen
author_sort Voss, Jan Oliver
collection PubMed
description OBJECTIVES: Different parameters have been identified in patients with oral squamous cell carcinomas (OSCC) that have a serious impact on survival, including residual tumour and extracapsular spread. Moreover, other factors, including the lymph node ratio (LNR) and lymph node yield (LNY), have been suggested as prognostic markers. MATERIAL AND METHODS: This retrospective study included patients diagnosed with OSCC and cervical lymph node metastases during the years 2010–2020. Patients’ records were evaluated regarding lymph node status, final therapy regime, tumour recurrence, time to death, tumour association with death, disease-free survival (DSF), and overall survival (OS). RESULTS: In 242 patients with a mean age of 63.57 ± 11.24 years, treated either by selective neck dissection (SND; n = 70) or by modified radical neck dissection (MRND; n = 172), 5772 lymph nodes were detected. The LNR and LNY were identified as independent risk factors in OS and DFS. The optimal cut-off point for the LNY was ≥ 17 lymph nodes in the SND and ≥ 27 lymph nodes in the MRND group. The metastatic lymph node clearance (MLNC) was established as a score to relate the LNR and LNY to the extent of lymph node removal. Survival analysis showed statistically significant differences among score levels. CONCLUSIONS: As information about the extent of nodal dissection is excluded from LNR and LNY, we propose the use of a new scoring system comprising individual cut-off values for LNY and LNR with regard to the extent of neck dissection. CLINICAL RELEVANCE: MLNC might help to identify high-risk OSCC patients with metastatic lymph nodes.
format Online
Article
Text
id pubmed-9643253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96432532022-11-15 Prognostic value of lymph node involvement in oral squamous cell carcinoma Voss, Jan Oliver Freund, Lea Neumann, Felix Mrosk, Friedrich Rubarth, Kerstin Kreutzer, Kilian Doll, Christian Heiland, Max Koerdt, Steffen Clin Oral Investig Original Article OBJECTIVES: Different parameters have been identified in patients with oral squamous cell carcinomas (OSCC) that have a serious impact on survival, including residual tumour and extracapsular spread. Moreover, other factors, including the lymph node ratio (LNR) and lymph node yield (LNY), have been suggested as prognostic markers. MATERIAL AND METHODS: This retrospective study included patients diagnosed with OSCC and cervical lymph node metastases during the years 2010–2020. Patients’ records were evaluated regarding lymph node status, final therapy regime, tumour recurrence, time to death, tumour association with death, disease-free survival (DSF), and overall survival (OS). RESULTS: In 242 patients with a mean age of 63.57 ± 11.24 years, treated either by selective neck dissection (SND; n = 70) or by modified radical neck dissection (MRND; n = 172), 5772 lymph nodes were detected. The LNR and LNY were identified as independent risk factors in OS and DFS. The optimal cut-off point for the LNY was ≥ 17 lymph nodes in the SND and ≥ 27 lymph nodes in the MRND group. The metastatic lymph node clearance (MLNC) was established as a score to relate the LNR and LNY to the extent of lymph node removal. Survival analysis showed statistically significant differences among score levels. CONCLUSIONS: As information about the extent of nodal dissection is excluded from LNR and LNY, we propose the use of a new scoring system comprising individual cut-off values for LNY and LNR with regard to the extent of neck dissection. CLINICAL RELEVANCE: MLNC might help to identify high-risk OSCC patients with metastatic lymph nodes. Springer Berlin Heidelberg 2022-07-27 2022 /pmc/articles/PMC9643253/ /pubmed/35895143 http://dx.doi.org/10.1007/s00784-022-04630-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Voss, Jan Oliver
Freund, Lea
Neumann, Felix
Mrosk, Friedrich
Rubarth, Kerstin
Kreutzer, Kilian
Doll, Christian
Heiland, Max
Koerdt, Steffen
Prognostic value of lymph node involvement in oral squamous cell carcinoma
title Prognostic value of lymph node involvement in oral squamous cell carcinoma
title_full Prognostic value of lymph node involvement in oral squamous cell carcinoma
title_fullStr Prognostic value of lymph node involvement in oral squamous cell carcinoma
title_full_unstemmed Prognostic value of lymph node involvement in oral squamous cell carcinoma
title_short Prognostic value of lymph node involvement in oral squamous cell carcinoma
title_sort prognostic value of lymph node involvement in oral squamous cell carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643253/
https://www.ncbi.nlm.nih.gov/pubmed/35895143
http://dx.doi.org/10.1007/s00784-022-04630-7
work_keys_str_mv AT vossjanoliver prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT freundlea prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT neumannfelix prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT mroskfriedrich prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT rubarthkerstin prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT kreutzerkilian prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT dollchristian prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT heilandmax prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma
AT koerdtsteffen prognosticvalueoflymphnodeinvolvementinoralsquamouscellcarcinoma